Cancerous Conditions Accelerate the Aging of Skeletal Muscle via Mitochondrial DNA Damage
Authors:
- Yi LuoYi Luo
- Rina Fujiwara-TaniRina Fujiwara-Tani
- Isao KawaharaIsao Kawahara
- Kei GotoKei Goto
- Shota NukagaShota Nukaga
- Ryoichi NishidaRyoichi Nishida
- Chie NakashimaChie Nakashima
- Takamitsu SasakiTakamitsu Sasaki
- Yoshihiro MiyagawaYoshihiro Miyagawa
- Ruiko OgataRuiko Ogata
- Kiyomu FujiiKiyomu Fujii
- Hitoshi OhmoriHitoshi Ohmori
Open Access
- 27 June 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7060
Abstract
Skeletal muscle aging and sarcopenia result in similar changes in the levels of aging markers. However, few studies have examined cancer sarcopenia from the perspective of aging. Therefore, this study investigated aging in cancer sarcopenia and explored its causes in vitro and in vivo. In mouse aging, in vitro cachexia, and mouse cachexia models, skeletal muscles showed similar changes in aging markers including oxidative stress, fibrosis, reduced muscle differentiation potential, and telomere shortening. Furthermore, examination of mitochondrial DNA from skeletal muscle revealed a 5 kb deletion in the major arc; truncation of complexes I, IV, and V in the electron transport chain; and reduced oxidative phosphorylation (OXPHOS). The mouse cachexia model demonstrated high levels of high-mobility group box-1 (HMGB1) and tumor necrosis factor-α (TNFα) in cancer ascites. Continuous administration of neutralizing antibodies against HMGB1 and TNFα in this model reduced oxidative stress and abrogated mitochondrial DNA deletion. These results suggest that in cancer sarcopenia, mitochondrial oxidative stress caused by inflammatory cytokines leads to mitochondrial DNA damage, which in turn leads to decreased OXPHOS and the promotion of aging.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (21K06926, 19K16564, 22K11423, 22K17655, 23K16547, 21K11223, 23K10481, 20K21659)
This publication has 60 references indexed in Scilit:
- Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implicationsApoptosis, 2024
- Advanced Glycation End Products and Health: A Systematic ReviewAnnals of Biomedical Engineering, 2024
- Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2024
- Metabolomics‐driven discovery of therapeutic targets for cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2024
- Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2024
- Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints seriesJournal of Cachexia, Sarcopenia and Muscle, 2024
- Loss of FoxOs in muscle increases strength and mitochondrial function during agingJournal of Cachexia, Sarcopenia and Muscle, 2022
- Cell interactome in sarcopenia during agingJournal of Cachexia, Sarcopenia and Muscle, 2022
- Chromo-fluorogenic probes for β-galactosidase detectionAnalytical and Bioanalytical Chemistry, 2021
- Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancerThe Journal of Pathology, 2001